Conducting
basic research to discover innovative new drug candidate compounds
A new compound produced
in drug discovery research undergoes through preclinical studies using various
cells, experimental animals and animal models to expect the effects and adverse
reactions in humans. This step is followed by human clinical trials to estimate
medical efficacy and safety, which, if successful, indicate that the candidate
has potential to give as a new drug. Regulatory authorities issue numerous
guidelines and standards regarding these studies for clarifying drug safety,
efficacy, and quality, all of which need be carried out in testing facilities
that have been approved by the regulatory authorities.
Development of new
drugs is perceived as a very difficult process, which can be described from
many different points of view; science and business level behind a new drug
launch do not necessary match. Therefore, general outlook of the contemporary
pharmaceutical industry is, despite of its some spectacular successes, that of convinced
dissatisfaction globally, more is spent on drug discovery and development every
year and less is delivered, in terms of radical innovation, we would like to
discuss this part of drug research and development and Clinical Trials at Drug
Discovery Congress 2018.
Currently, we are organizing 5th Annual Congress on Chemistry in Drug Discovery & Designing
during April 16-17, 2018 at Dubai, UAE. The scientific-program of this
conference is a rich mix of keynote lectures from world class scientists, Interactive
Sessions & Sub-sessions, panel discussions, poster competitions and Young
Researcher Forum.
For more details Contact us:
Monty Williams
Program Manager
Drug Discovery Congress 2018
drugdesign@pharmaceticalconferences.org